Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes

被引:120
|
作者
Rabesandratana, H
Toutant, JP
Reggio, H
Vidal, M
机构
[1] Univ Montpellier 2, UMR 5539, F-34095 Montpellier, France
[2] Hop St Eloi, Cent Hematol Lab, Montpellier, France
[3] INRA, F-34060 Montpellier, France
关键词
D O I
10.1182/blood.V91.7.2573.2573_2573_2580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosomes are membrane vesicles released by reticulocytes during their maturation into erythrocytes. They have a clearing function because of their enrichment with some proteins known to decrease or disappear from the cell surface during maturation, eg, acetylcholinesterase (AChE) and transferrin receptor (TIR), respectively. To better understand the molecular events leading to protein sorting in exosomes, we analyzed the expression of glycosylphosphatidylinositol (GPI)-anchored proteins on the exosome surface through a technique involving bead coupling and flow cytometry immunodetection. The presence of AChE, decay-accelerating factor (DAF), membrane inhibitor of reactive lysis (MIRL), and lymphocyte function-associated antigen 3 (LFA-3) on the surface of exosomes obtained from normal and paroxysmal nocturnal hemoglobinuria (PNH) reticulocytes, suggests that (1) the GPI anchor is efficiently sorted during exosome formation, (2) exosome release could account for the observed discrepancy in GPI-protein expression between reticulocytes and erythrocytes from PNH patients, and (3) exosomes could have another physiologic function related to controlling membrane attack complex formation. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2573 / 2580
页数:8
相关论文
共 50 条
  • [41] PROTECTION OF RAT ENDOTHELIAL-CELLS FROM PRIMATE COMPLEMENT-MEDIATED LYSIS BY EXPRESSION OF HUMAN CD59 AND/OR DECAY-ACCELERATING FACTOR
    CHARREAU, B
    CASSARD, A
    TESSON, L
    LEMAUFF, B
    NAVENOT, JM
    BLANCHARD, D
    LUBLIN, D
    SOULILLOU, JP
    ANEGON, I
    TRANSPLANTATION, 1994, 58 (11) : 1222 - 1229
  • [42] COXSACKIEVIRUS B3 ADAPTED TO GROWTH IN RD CELLS BINDS TO DECAY-ACCELERATING FACTOR (CD55)
    BERGELSON, JM
    MOHANTY, JG
    CROWELL, RL
    JOHN, NFS
    LUBLIN, DM
    FINBERG, RW
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1903 - 1906
  • [43] FLOW CYTOMETRIC ANALYSIS OF DECAY-ACCELERATING FACTOR (CD55) ON NEUTROPHILS FROM APLASTIC-ANEMIA PATIENTS
    FORES, R
    ALCOCER, M
    DIEZMARTIN, JL
    FERNANDEZ, MN
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) : 728 - 730
  • [44] Expression and regulation of complement regulatory proteins CD59 and decay-accelerating factor (DAF) on endothelial cells (EC).
    Mason, JC
    Yarwood, H
    Harrison, AA
    Davies, KAA
    Haskard, DO
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 277 - 277
  • [45] Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia
    Lawrence, DW
    Bruyninckx, WJ
    Louis, NA
    Lublin, DM
    Stahl, GL
    Parkos, CA
    Colgan, SP
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07): : 999 - 1010
  • [46] Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis
    Lin, F
    Salant, DJ
    Meyerson, H
    Emancipator, S
    Morgan, BP
    Medof, ME
    JOURNAL OF IMMUNOLOGY, 2004, 172 (04): : 2636 - 2642
  • [47] Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor
    Kinoshita, Taroh
    SEMINARS IN HEMATOLOGY, 2018, 55 (03) : 136 - 140
  • [48] Expression of the Decay-Accelerating Factor (CD55) in Renal Transplants-A Possible Prediction Marker of Allograft Survival
    Brodsky, Sergey V.
    Nadasdy, Gyongyi M.
    Pelletier, Ronald
    Satoskar, Anjali
    Birmingham, Daniel J.
    Hadley, Gregg A.
    Obeidat, Khaled
    Nadasdy, Tibor
    TRANSPLANTATION, 2009, 88 (04) : 457 - 464
  • [49] Bee Venom Alleviates Atopic Dermatitis Symptoms through the Upregulation of Decay-Accelerating Factor (DAF/CD55)
    Kim, Yenny
    Lee, Youn-Woo
    Kim, Hangeun
    Chung, Dae Kyun
    TOXINS, 2019, 11 (05):
  • [50] Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)
    Qian, YM
    Haino, M
    Kelly, K
    Song, WC
    IMMUNOLOGY, 1999, 98 (02) : 303 - 311